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Purpose of the study
To introduce and audit the effectiveness of a system to
screen for chronic kidney disease (CKD) and monitor for
nephrotoxicity of antiretrovirals in HIV-positive patients.
Methods
Aging population, co-morbidities, antiretroviral therapies
and HIV infection increase the risk of renal morbidity. The
frequency of screening for CKD, and the frequency of
monitoring for nephrotoxicity of antiretrovirals in HIV-
positive patients attending outpatient clinics was audited.
Of patients who required regular monitoring of GFR/uri-
nalysis based on their antiretroviral therapy or risk factors
for CKD, 0% of patients had a documented estimation of
GFR (n = 31), 51.6% had urinalysis at an appropriate fre-
quency (n = 31), 11.76% had serum phosphate measure-
ment at an appropriate frequency (n = 17). A series of
interventions were implemented to highlight the recom-
mended frequency of screening and monitoring, and
allow quick identification of patients requiring urinalysis/
GFR estimation/serum phosphate measurement (tenofo-
vir). A traffic light colour-coded system was used to group
patients into three categories based on the frequency at
which they required urinalysis/GFR estimation. The cate-
gories were based on recommendations from the IDSA
and a review of current literature. Red, amber and green
stickers were attached to each patient's chart indicating
the need for 3-monthly/at next appointment screening, 6-
monthly screening or yearly screening, respectively. Edu-
cational presentations, posters, and an amended system
to order bloods, which included an option for eGFR meas-
urement, were provided to highlight and facilitate the rec-
ommended screening schedule.
Summary of results
Preliminary results indicate that the system has resulted in
an improvement in screening for CKD and monitoring for
nephrotoxicity of antiretrovirals.
Conclusion
Improved screening will allow identification of patients
who require interventions to reduce cardiovascular risk
and progression of CKD, timely referral and planning for
renal replacement therapy, and early identification of
nephrotoxicity due to antiretrovirals.
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